Proposed Peer-Review Rule Calls Academicians Biased

File photo Scientists are debating the implications of a proposed new set of rules requiring federal agencies to consult outside scientists systematically when revising regulations. The White House Office of Management and Budget (OMB) says that the "peer-review" requirements are meant to "further engage the scientific community in the regulatory process." Under the draft rules, independent scientists must review significant amendments to any federal agency rule, which includes amendments tha

Written byPeg Brickley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientists are debating the implications of a proposed new set of rules requiring federal agencies to consult outside scientists systematically when revising regulations. The White House Office of Management and Budget (OMB) says that the "peer-review" requirements are meant to "further engage the scientific community in the regulatory process."

Under the draft rules, independent scientists must review significant amendments to any federal agency rule, which includes amendments that carry an annual impact of $100 million (US) or more. Some fear, however, that the proposal has a built-in trapdoor that will drop many academic scientists out of the process of formulating scientific regulations: Anyone receiving government agency funds is considered tainted when it comes to serving as a peer reviewer for that agency. The suggestion has some academics up in arms.

"They are trying to get university scientists out of the picture here," says David Michaels, research professor and epidemiologist in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies